Cargando…

Author Correction: Validation of the BOADICEA model for predicting the likelihood of carrying pathogenic variants in eight breast and ovarian cancer susceptibility genes

Detalles Bibliográficos
Autores principales:	Møller, Nanna Bæk, Boonen, Desirée Sofie, Feldner, Elisabeth Simone, Hao, Qin, Larsen, Martin, Lænkholm, Anne‑Vibeke, Borg, Åke, Kvist, Anders, Törngren, Therese, Jensen, Uffe Birk, Boonen, Susanne Eriksen, Thomassen, Mads, Terkelsen, Thorkild
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Author Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504286/ https://www.ncbi.nlm.nih.gov/pubmed/37714994 http://dx.doi.org/10.1038/s41598-023-42606-z

Ejemplares similares

Validation of the BOADICEA model for predicting the likelihood of carrying pathogenic variants in eight breast and ovarian cancer susceptibility genes
por: Møller, Nanna Bæk, et al.
Publicado: (2023)

Germline pathogenic variants associated with ovarian cancer: A historical overview
por: Johansen, Emma Lund, et al.
Publicado: (2022)

The BOADICEA model of genetic susceptibility to breast and ovarian cancer
por: Antoniou, A C, et al.
Publicado: (2004)

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
por: Antoniou, A C, et al.
Publicado: (2008)

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
por: Antoniou, A C, et al.
Publicado: (2008)

Remarks on the BOADICEA model of genetic susceptibility to breast and ovarian cancer
por: van Asperen, C J, et al.
Publicado: (2005)

Evaluation of Nine Somatic Variant Callers for Detection of Somatic Mutations in Exome and Targeted Deep Sequencing Data
por: Krøigård, Anne Bruun, et al.
Publicado: (2016)

Clinical software development for the Web: lessons learned from the BOADICEA project
por: Cunningham, Alex P, et al.
Publicado: (2012)

BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer
por: Nilsson, Martin P., et al.
Publicado: (2017)

Reply: Remarks on the BOADICEA model of genetic susceptibility to breast and ovarian Cancer Research UK
por: Antoniou, A C, et al.
Publicado: (2005)

Evaluation of the BOADICEA risk assessment model in women with a family history of breast cancer
por: Ståhlbom, Anne Kinhult, et al.
Publicado: (2011)

Use of the BOADICEA Web Application in clinical practice: appraisals by clinicians from various countries
por: Brédart, Anne, et al.
Publicado: (2017)

Streamlining Decision Making in Contralateral Risk-Reducing Mastectomy: Impact of PREDICT and BOADICEA Computations
por: de Silva, Tania Samantha, et al.
Publicado: (2018)

Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction Model
por: Mavaddat, Nasim, et al.
Publicado: (2023)

Deleterious mis‐splicing of STK11 caused by a novel single‐nucleotide substitution in the 3′ polypyrimidine tract of intron five
por: Terkelsen, Thorkild, et al.
Publicado: (2020)

Machine learning techniques for personalized breast cancer risk prediction: comparison with the BCRAT and BOADICEA models
por: Ming, Chang, et al.
Publicado: (2019)

Prospective validation of the breast cancer risk prediction model BOADICEA and a batch-mode version BOADICEACentre
por: MacInnis, R J, et al.
Publicado: (2013)

BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface
por: Lee, A J, et al.
Publicado: (2014)

Incorporating Truncating Variants in PALB2, CHEK2 and ATM into the BOADICEA Breast Cancer Risk Model
por: Lee, Andrew J., et al.
Publicado: (2016)

BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors
por: Lee, Andrew, et al.
Publicado: (2019)

Machine learning-based lifetime breast cancer risk reclassification compared with the BOADICEA model: impact on screening recommendations
por: Ming, Chang, et al.
Publicado: (2020)

Correction: BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors
por: Lee, Andrew, et al.
Publicado: (2019)

Prospective validation of the BOADICEA multifactorial breast cancer risk prediction model in a large prospective cohort study
por: Yang, Xin, et al.
Publicado: (2022)

Towards a better understanding of the role of psychological variables in arthritis outcome research
por: Boonen, Annelies
Publicado: (2010)

Clonal expansion and linear genome evolution through breast cancer progression from pre-invasive stages to asynchronous metastasis
por: Krøigård, Anne Bruun, et al.
Publicado: (2015)

Identification of metastasis driver genes by massive parallel sequencing of successive steps of breast cancer progression
por: Krøigård, Anne Bruun, et al.
Publicado: (2018)

Expanding the genotype–phenotype spectrum in hereditary colorectal cancer by gene panel testing
por: Rohlin, Anna, et al.
Publicado: (2016)

Precision Oncology of High-Grade Ovarian Cancer Defined through Targeted Sequencing
por: Wessman, Sandra, et al.
Publicado: (2021)

Genetic clinicians' confidence in BOADICEA comprehensive breast cancer risk estimates and counselees' psychosocial outcomes: A prospective study
por: Brédart, Anne, et al.
Publicado: (2022)

RNA profiling reveals familial aggregation of molecular subtypes in non-BRCA1/2 breast cancer families
por: Larsen, Martin J, et al.
Publicado: (2014)

Solvency II solvency capital requirement for life insurance companies based on expected shortfall
por: Boonen, Tim J.
Publicado: (2017)

The effect of anti-inflammatory treatment on depressive symptoms in spondyloarthritis: does the type of drug matter?
por: Webers, Casper, et al.
Publicado: (2022)

Genomic Analyses of Breast Cancer Progression Reveal Distinct Routes of Metastasis Emergence
por: Krøigård, Anne Bruun, et al.
Publicado: (2017)

Monocytes/Macrophages Upregulate the Hyaluronidase HYAL1 and Adapt Its Subcellular Trafficking to Promote Extracellular Residency upon Differentiation into Osteoclasts
por: Puissant, Emeline, et al.
Publicado: (2016)

BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families
por: Antoniou, Antonis C, et al.
Publicado: (2006)

Validation of the BOADICEA model and a 313-variant polygenic risk score for breast cancer risk prediction in a Dutch prospective cohort
por: Lakeman, Inge M. M., et al.
Publicado: (2020)

Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation in Asian breast cancer patients
por: Ang, Boon Hong, et al.
Publicado: (2022)

Assessing the relative efficacy of different agents based on the outcomes from meta-analyses
por: Boonen, S, et al.
Publicado: (2008)

The challenging interplay between rheumatoid arthritis, ageing and comorbidities
por: van Onna, Marloes, et al.
Publicado: (2016)

Rheumatoid factor and anti-CCP do not predict progressive joint damage in patients with early rheumatoid arthritis treated with prednisolone: a randomised study
por: Hafström, Ingiäld, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_q2vuf8992sle4eiim9gddla1bo